Safety and preliminary efficacy of different doses of fecal microbiota capsule transplantation combined with anti-PD-1 inhibitor for patients with advanced malignant solid tumors

被引：0
|
作者：
Zhu, Wenyu
Chu, Yunqian
Xue, Ya
Hu, Muni
Dai, Hanjue
Xian, Qingying
Jiang, Hua
机构：
[1] Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Dept Oncol, Changzhou, Jiangsu, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, State Key Lab Syst Med Canc,Renji Hosp,Sch Med, NHC Key Lab Digest Dis,Div Gastroenterol & Hepato, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14622
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Fecal microbiota transplantation combined with anti-PD-1 inhibitor for unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor.
    Park, Sook Ryun
    Kim, Gihyeon
    Kim, Yunjae
    Cho, Beomki
    Kim, Sang-Yeob
    Do, Eun-Ju
    Bae, Dong-Jun
    Kweon, Mi-Na
    Song, Joon Seon
    Park, Hansoo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
    Kim, Yunjae
    Kim, Gihyeon
    Kim, Sujeong
    Cho, Beomki
    Kim, Sang-Yeob
    Do, Eun-Ju
    Bae, Dong-Jun
    Kim, Seungil
    Kweon, Mi-Na
    Song, Joon Seon
    Park, Sang Hyoung
    Hwang, Sung Wook
    Kim, Mi-Na
    Kim, Yeongmin
    Min, Kyungchan
    Kim, Sung-Han
    Adams, Mark D.
    Lee, Charles
    Park, Hansoo
    Park, Sook Ryun
    [J]. CELL HOST & MICROBE, 2024, 32 (08)
  • [3] Fecal microbiota transplantation followed by anti-PD-1 treatment in patients with advanced melanoma.
    Miller, Wilson H.
    Routy, Bertrand
    Jamal, Rahima
    Ernst, D. Scott
    Logan, Diane
    Esfahani, Khashayar
    Belanger, Karl
    Elkrief, Arielle
    Lapointe, Rejean
    Thebault, Pamela
    Ponce, Mayra
    Parvathy, Seema Nair
    Messaoudene, Meriem
    Silverman, Micheal
    Maleki, Saman
    Lenehan, John Gordon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] The clinical activity and safety of anlotinib combined with anti-PD-1 antibodies in patients with advanced solid tumors.
    Yuan, Min
    Fang, Juemin
    Zhu, Zhongzheng
    Mao, Wei
    Wang, Hui
    Liu, Weixing
    Qian, Hong
    Wu, Jianguo
    Guo, Xianling
    Xu, Qing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Anti-PD-1 for patients with leptomeningeal metastasis from advanced solid tumors: Efficacy, safety, and biomarkers of response.
    Naidoo, Jarushka
    Schreck, Karisa C.
    Hu, Chen
    Douville, Christopher Blair
    Santa-Maria, Cesar Augusto
    Connolly, Roisin M.
    Holdhoff, Matthias
    Lipson, Evan J.
    Parkinson, Rose
    Riemer, Joanne
    Barnes, Amanda
    Venkatesan, Arun
    Bettegowda, Chetan
    Grossman, Stuart A.
    Brahmer, Julie R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study
    Xiong, Jianping
    Ouyang, Weiwei
    Yang, Mengxiang
    Gao, Zhenyuan
    Zhou, Huan
    Lou, Hanmei
    Guo, Yabing
    Xu, Zhongyuan
    Zheng, Ling
    Liu, Ying
    Wang, Zhongfeng
    Sun, Ping
    Niyazi, Huerxidan
    Wang, Jianhua
    Chen, Yan
    Zhang, Baihui
    Li, Lingyan
    Kang, Xiaoyan
    Guo, Weijian
    [J]. ADVANCES IN THERAPY, 2024,
  • [7] Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
    Routy, Bertrand
    Lenehan, John G.
    Miller, Wilson H.
    Jamal, Rahima
    Messaoudene, Meriem
    Daisley, Brendan A.
    Hes, Cecilia
    Al, Kait F.
    Martinez-Gili, Laura
    Puncochar, Michal
    Ernst, Scott
    Logan, Diane
    Belanger, Karl
    Esfahani, Khashayar
    Richard, Corentin
    Ninkov, Marina
    Piccinno, Gianmarco
    Armanini, Federica
    Pinto, Federica
    Krishnamoorthy, Mithunah
    Figueredo, Rene
    Thebault, Pamela
    Takis, Panteleimon
    Magrill, Jamie
    Ramsay, LeeAnn
    Derosa, Lisa
    Marchesi, Julian R.
    Parvathy, Seema Nair
    Elkrief, Arielle
    Watson, Ian R.
    Lapointe, Rejean
    Segata, Nicola
    Haeryfar, S. M. Mansour
    Mullish, Benjamin H.
    Silverman, Michael S.
    Burton, Jeremy P.
    Vareki, Saman Maleki
    [J]. NATURE MEDICINE, 2023, 29 (08) : 2121 - +
  • [8] Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
    Bertrand Routy
    John G. Lenehan
    Wilson H. Miller
    Rahima Jamal
    Meriem Messaoudene
    Brendan A. Daisley
    Cecilia Hes
    Kait F. Al
    Laura Martinez-Gili
    Michal Punčochář
    Scott Ernst
    Diane Logan
    Karl Belanger
    Khashayar Esfahani
    Corentin Richard
    Marina Ninkov
    Gianmarco Piccinno
    Federica Armanini
    Federica Pinto
    Mithunah Krishnamoorthy
    Rene Figueredo
    Pamela Thebault
    Panteleimon Takis
    Jamie Magrill
    LeeAnn Ramsay
    Lisa Derosa
    Julian R. Marchesi
    Seema Nair Parvathy
    Arielle Elkrief
    Ian R. Watson
    Rejean Lapointe
    Nicola Segata
    S.M. Mansour Haeryfar
    Benjamin H. Mullish
    Michael S. Silverman
    Jeremy P. Burton
    Saman Maleki Vareki
    [J]. Nature Medicine, 2023, 29 : 2121 - 2132
  • [9] Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma
    Li, Jing-jing
    Wang, Jiu-hong
    Dingv, Ya
    Li, Dan-dan
    Wen, Xi-zhi
    Zhao, Jing-jing
    Jiang, Hang
    Liu, Xing
    Huang, Fu-xue
    Zhang, Xiao-shi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (05) : 1159 - 1169
  • [10] Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma
    Jing-jing Li
    Jiu-hong Wang
    Ya Dingv
    Dan-dan Li
    Xi-zhi Wen
    Jing-jing Zhao
    Hang Jiang
    Xing Liu
    Fu-xue Huang
    Xiao-shi Zhang
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1159 - 1169
12345